Personalised Medicine Approach For Fluoropyrimidine-based Therapies – Guidance for DPD testing

New guidance, prepared by Dr Paul Ross at GSTT, has been published by the UK Chemotherapy Board and endorsed by the ACP.  It provides recommendations for DPD testing in patients starting a fluoropyrimidine with advice on interpretation of the results.